LECAP Asset Management’s Globus Medical GMED Stock Holding History

LECAP Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,778	Closed	-$1.2M	–	318
2025 Q4	$1.2M	Buy	+13,778	New	+$1.05M	0.48%	76

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LECAP Asset Management's GMED Position: Q1 2026 in Review

LECAP Asset Management sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 13,778 shares — an estimated $1.2M sold.

LECAP Asset Management first reported a position in GMED in Q4 2025 and held it in 1 quarter. The position peaked at $1.2M in Q4 2025. 610 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

LECAP Asset Management reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
LECAP Asset Management sold 13,778 Globus Medical shares in Q1 2026, an estimated $1.2M.
LECAP Asset Management first reported a position in Globus Medical in Q4 2025 and held it in 1 quarter.
LECAP Asset Management's Globus Medical position peaked at $1.2M in Q4 2025.
610 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on LECAP Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.